BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,255,748 | +154.0% | 4,802,749 | +206.6% | 0.09% | +170.6% |
| Q2 2023 | $71,367,690 | +1963.8% | 1,566,455 | +1737.3% | 0.03% | +1600.0% |
| Q1 2023 | $3,458,105 | -87.8% | 85,259 | -84.6% | 0.00% | -86.7% |
| Q4 2022 | $28,232,182 | +634.8% | 553,898 | +676.6% | 0.02% | +650.0% |
| Q3 2022 | $3,842,000 | -14.3% | 71,323 | +2.1% | 0.00% | 0.0% |
| Q2 2022 | $4,485,000 | -43.9% | 69,830 | -32.3% | 0.00% | -33.3% |
| Q1 2022 | $7,996,000 | +38.8% | 103,124 | +53.7% | 0.00% | +50.0% |
| Q4 2021 | $5,760,000 | +4.2% | 67,093 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $5,526,000 | +31.6% | 68,735 | +32.1% | 0.00% | 0.0% |
| Q2 2021 | $4,199,000 | -3.7% | 52,019 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $4,362,000 | -80.0% | 51,829 | -80.9% | 0.00% | -77.8% |
| Q4 2020 | $21,798,000 | +2.1% | 271,679 | +2.4% | 0.01% | -10.0% |
| Q3 2020 | $21,343,000 | -75.2% | 265,412 | -72.4% | 0.01% | -77.3% |
| Q2 2020 | $85,921,000 | +14.7% | 963,366 | +4.4% | 0.04% | -12.0% |
| Q1 2020 | $74,917,000 | -10.0% | 922,748 | -7.3% | 0.05% | +13.6% |
| Q4 2019 | $83,246,000 | +7.5% | 995,535 | +12.5% | 0.04% | +4.8% |
| Q3 2019 | $77,421,000 | +20.0% | 885,111 | +12.4% | 0.04% | +23.5% |
| Q2 2019 | $64,515,000 | +0.9% | 787,723 | +0.2% | 0.03% | 0.0% |
| Q1 2019 | $63,910,000 | +62.8% | 785,996 | +31.8% | 0.03% | +41.7% |
| Q4 2018 | $39,247,000 | -14.6% | 596,285 | +0.1% | 0.02% | +4.3% |
| Q3 2018 | $45,941,000 | +4.3% | 595,947 | -0.1% | 0.02% | 0.0% |
| Q2 2018 | $44,059,000 | +6.8% | 596,686 | -6.0% | 0.02% | +9.5% |
| Q1 2018 | $41,263,000 | +39.4% | 634,438 | +38.6% | 0.02% | +50.0% |
| Q4 2017 | $29,599,000 | +2.7% | 457,905 | -0.3% | 0.01% | 0.0% |
| Q3 2017 | $28,807,000 | +8.6% | 459,076 | +4.8% | 0.01% | +7.7% |
| Q2 2017 | $26,514,000 | +22.4% | 437,960 | +4.9% | 0.01% | +18.2% |
| Q1 2017 | $21,656,000 | +17.1% | 417,598 | +0.1% | 0.01% | +10.0% |
| Q4 2016 | $18,494,000 | -6.7% | 417,090 | +0.2% | 0.01% | 0.0% |
| Q3 2016 | $19,818,000 | +5.4% | 416,340 | +0.2% | 0.01% | 0.0% |
| Q2 2016 | $18,794,000 | +9.6% | 415,616 | -0.4% | 0.01% | +11.1% |
| Q1 2016 | $17,146,000 | +6.2% | 417,390 | -1.4% | 0.01% | +12.5% |
| Q4 2015 | $16,152,000 | +15.5% | 423,382 | -0.5% | 0.01% | +14.3% |
| Q3 2015 | $13,984,000 | -53.1% | 425,713 | -0.2% | 0.01% | -50.0% |
| Q2 2015 | $29,829,000 | +1.4% | 426,552 | -0.7% | 0.01% | +7.7% |
| Q1 2015 | $29,424,000 | -6.0% | 429,546 | +0.6% | 0.01% | -7.1% |
| Q4 2014 | $31,306,000 | +1.9% | 427,150 | -0.2% | 0.01% | 0.0% |
| Q3 2014 | $30,733,000 | -42.2% | 428,210 | -41.8% | 0.01% | -39.1% |
| Q2 2014 | $53,178,000 | -2.0% | 735,515 | -0.3% | 0.02% | -11.5% |
| Q1 2014 | $54,269,000 | +4.4% | 737,545 | -1.3% | 0.03% | +4.0% |
| Q4 2013 | $51,972,000 | +75.5% | 747,265 | +65.8% | 0.02% | +56.2% |
| Q3 2013 | $29,610,000 | -5.6% | 450,761 | -0.4% | 0.02% | -11.1% |
| Q2 2013 | $31,359,000 | – | 452,708 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |